Bone Marrow Transplant Clinical Trials
| For further information on clinical trial eligibility or informed consent call:
For appointment scheduling call:
|
Please Note: Eligibility Criteria are subject to change. The Office of Clinical Research (603-650-8644) is able to provide you with the most current eligibility and exclusion criteria. Any treatment to be undertaken must ultimately be determined on an individual basis by the patient and those involved in the patient's treatment.
Bone Marrow Transplant Clinical Trials
| Disease |
Protocol Number |
Sponsored By |
Details |
| Leukemia |
CALGB 10001 |
CALGB |
Details |
A phase II trial of sequential chemotherapy, imatinib mesylate (Gleevec, STI571) (NSC#716051, IND#61135), and transplantation for adults with newly diagnosed Ph+ acute lymphoblastic leukemia by the CALGB and SWOG".
|
| Non-Hodgkin's Lymphoma |
CALGB 59903 |
CALGB |
Details |
A randomized phase III trial comparing early high dose chemoradiotherapy and an autologous stem cell transplant to conventional dose CHOP chemotherapy plus rituximab for CD 20+B cell lymphomas ( with possible alte autologous stem cell transplant) for patients with diffuse aggressive non-Hodgkin's lymphoma in the high-intermediate and high risk international classification prognostic groups.
|
| Hematologic Malignancies |
D0345 |
Dartmouth College |
Details |
Non myeloablative chemotherapy followed by HLA-matched related allogeneic stem cell transplantion for hematologic malignancies
|
| Hematologic Malignancies |
D0546 |
Dartmouth College |
Details |
A prospective feasibility and cost analysis of peripheral blood stem cell mobilization using Pegfilgrastim in patients with hematologic malignancies
|
| Other |
D0227 |
Dartmouth College |
Details |
Immune Mobilization of autologous peripheral blood stem cells using interleukin-2 and GM-CSF
|
| Multiple Myeloma |
D0416 |
Dartmouth College |
Details |
Adoptive cellular immunotherapy following autologous peripheral blood stem cell transplantation for multiple myeloma
|
| Cancer - NOS |
D0506 |
Dartmouth College |
Details |
Functional recovery after Bone Marrow Transplantation (BMT)
|
| Hematologic Malignancies |
D0529 |
Dartmouth College |
Details |
Protocol to obtain bone marrow for research
|
| Hematologic Malignancies |
F0635 |
|
Details |
(W0525) AMD3100-CUP001: "Compassionate Use Protocol For The Use of AMD3100 to Mobilize Peripheral Blood Stem Cells For Collection and Transplantation"
|
| Multiple Myeloma |
D0717 |
Dartmouth College |
Details |
Adoptive Cellular Immunotherapy Following Autologous Peripheral Blood Stem Cell Transplantation for Multiple Myeloma
|
| Hematologic Malignancies |
C50403 |
CALGB |
Details |
A Randomized Phase II Trial of Maintenance vs Consolidation Bortezomib Therapy Following Aggressive Chemo-Immunotherapy and Autologous Stem Cell Transplant for Previously Untreated Mantle Cell Lymphoma
|
|
